MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Synucleinopathies"

  • 2025 International Congress

    Real world application of alpha-synuclein skin biopsy in the diagnosis of synucleinopathies at a tertiary care center

    C. Yu, C. Cooper (Nashville, USA)

    Objective: The goal of this study is to review the real-world application of alpha-synuclein skin biopsy at a tertiary care center. Background: Synucleniopathies including Parkinson’s…
  • 2025 International Congress

    Validation of CSF Alpha-synuclein SAA in an Autopsy Cohort with Systemic Assessment of Lewy Pathology Including the Body

    M. Kurihara, T. Matsubara, K. Satoh, A. Arakawa, M. Hara, K. Kanemaru, A. Iwata, S. Murayama, Y. Saito (Tokyo, Japan)

    Objective: Based on the recent recommendations by international neuropathologists [1], we attempted to evaluate the diagnostic accuracy of cerebrospinal fluid (CSF) alpha-synuclein (α-syn) seeding amplification…
  • 2025 International Congress

    Dopaminometer: A Smartphone-Based Application to Predict Striatal Dopaminergic Deficit in Prodromal and Manifest Parkinson’s disease

    K. Gunter, K. Groenewald, J. Klein, T. Aubourg, J. Razzaque, C. Lo, P. Ratti, L. van Hillegondsberg, J. Welch, A. Nastasa, K. Bradley, D. Mcgowan, B. Orso, P. Mattioli, M. Pardini, S. Raffa, F. Massa, D. Arnaldi, S. Arora, M. Hu (Oxford, United Kingdom)

    Objective: To assess the feasibility of a smartphone-based application (“Dopaminometer”) for predicting abnormal vs. normal dopamine transporter (DaT) scans and dopaminergic ratios in individuals with…
  • 2025 International Congress

    Impact of Skin Biopsy Detection of Phosphorylated Alpha-Synuclein and its Distribution Patterns on the Diagnosis of Synucleinopathies

    M. Chen, M. Christie (Houston, USA)

    Objective: To assess how skin biopsy detection of phosphorylated alpha-synuclein (P-SYN) and its distribution pattern impact the diagnosis of synucleinopathies, such as Parkinson’s disease (PD),…
  • 2025 International Congress

    Pathology Meets Clinical Practice: Unveiling the Pathological Evidence of Clinical Signs in Multiple System Atrophy

    E. Zhunusova, P. Panyakaew, C. Shambetova, R. Bhidayasiri (Bishkek, Kyrgyzstan)

    Objective: This study aimed to evaluate the pathological evidence of the core and supportive clinical features of multiple system atrophy (MSA) based on The Movement…
  • 2025 International Congress

    Biological Characteristics of Individuals with RBD: A Multicenter Prospective Longitudinal Cohort

    J. Feuerstein, E. Brown, L. Chahine, C. Gochanour, D. Lafontant, M. Marshall, T. Simuni, D. Weintraub (Aurora, USA)

    Objective: Examine baseline clinical and biological characteristics of participants with polysomnography-confirmed REM Sleep Behavior Disorder (RBD). Background: RBD is an early manifestation of underlying synucleinopathy…
  • 2025 International Congress

    Plasma Neurofilament Light Chain and Orthostatic Hypotension in Isolated REM Sleep Behavior Disorder: A Biomarker for α-Synucleinopathy Progression

    A. Calculli, D. Di Martino, P. Grillo, G. Bellini, C. Fazio, D. Comolli, D. Hoxhaj, S. Cerri, M. Terzaghi, A. Pisani (Pavia, Italy)

    Objective: This study aims to assess plasma NfL levels in iRBD and their utility in detecting early neurodegenerative changes. Background: Rapid-Eye-Movement (REM) sleep behavior disorder…
  • 2025 International Congress

    What Moves in the Night: Differences in Dream Quality Between REM Sleep Behavior Disorder and Trauma Associated Sleep Disorder

    J. Feuerstein, A. Amara, A. Zadra, C. Pickard-Deland, S. Holden (Aurora, USA)

    Objective: Explore differences in dream quality between REM Sleep Behavior Disorder (RBD) and Trauma Associated Sleep Disorder (TASD). Background: Idiopathic RBD is known to progress…
  • 2024 International Congress

    Clinical and epidemiological profile of Parkinson’s disease in India

    A. Kishore, R. Borgohain, KP. Divya, R. Rajan, P. Pal, H. Kumar, S. Mehta, N. Kumar, LK. Prashanth, S. Desai, R. Kandadai, R. Yadav, K. Shetty, P. Wadi, A. Aggarwal, P. Agarwal, M. Abbas, G. Wali, T. Ferreira, A. Srivastava, N. Kamble, M. Divya, S. Krishnan, L. Gonzalez-Ricardo, M. Chacko, M. Sharma (Kochi, India)

    Objective: To study the clinical profile and risk factors of Parkinson’s disease (PD) in India. Background: The current knowledge of clinical and epidemiological profile of…
  • 2024 International Congress

    Parkinson’s Progression Markers Initiative (PPMI): Investigating Biomarker Driven PD Progression

    B. Mcmahon, A. Siderowf, T. Simuni, C. Tanner, B. Mollenhauer, C. Coffey, D. Galasko, K. Poston, L. Chahine, R. Dobkin, T. Foroud, K. Kieburtz, D. Weintraub, K. Merchant, M. Frasier, T. Sherer, S. Chowdury, E. Brown, R. Alcalay, A. Videnovic, K. Fabrizio, E. Flagg, C. Stanley, K. Marek (Baltimore, USA)

    Objective: PPMI is a longitudinal, observational study enrolling PD participants, individuals at risk for PD, and healthy controls (HCs). The study investigates clinical, imaging, genetic…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 18
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley